Global Gene Editing Safety Assessment Services Supply, Demand and Key Producers, 2026-2032
The global Gene Editing Safety Assessment Services market size is expected to reach $ 1038 million by 2032, rising at a market growth of 17.8% CAGR during the forecast period (2026-2032).
Gene editing safety assessment services refer to third-party research, analytical testing, bioinformatics, and regulatory-support activities used to characterize the safety and genomic consequences of engineered edits in cells, tissues, animals, and clinical samples. The service scope centers on in silico risk screening, empirical off-target site nomination, targeted confirmation, on-target edit outcome characterization, detection of translocations and other structural variants, genome integrity analysis, biodistribution and tissue editing measurement, tumorigenicity or functional safety testing, and regulatory-ready interpretation. Typical workflows combine targeted amplicon sequencing, short- and long-read whole-genome sequencing, unbiased break-site mapping, cytogenetic assays, PCR, multi-omics, and validated bioinformatics, with study design adapted to nuclease, base-editing, prime-editing, and multiplex-editing systems. Customers primarily purchase stand-alone assays or integrated packages spanning discovery, lead optimization, preclinical development, IND-enabling studies, and clinical follow-up. The blended gross margin is approximately 55%.
This report is a detailed and comprehensive analysis of the world market for Gene Editing Safety Assessment Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Editing Safety Assessment Services that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Gene Editing Safety Assessment Services market
2. What is the demand of the global Gene Editing Safety Assessment Services market?
3. What is the year over year growth of the global Gene Editing Safety Assessment Services market?
4. What is the total value of the global Gene Editing Safety Assessment Services market?
5. Who are the Major Players in the global Gene Editing Safety Assessment Services market?
6. What are the growth factors driving the market demand?
Gene editing safety assessment services refer to third-party research, analytical testing, bioinformatics, and regulatory-support activities used to characterize the safety and genomic consequences of engineered edits in cells, tissues, animals, and clinical samples. The service scope centers on in silico risk screening, empirical off-target site nomination, targeted confirmation, on-target edit outcome characterization, detection of translocations and other structural variants, genome integrity analysis, biodistribution and tissue editing measurement, tumorigenicity or functional safety testing, and regulatory-ready interpretation. Typical workflows combine targeted amplicon sequencing, short- and long-read whole-genome sequencing, unbiased break-site mapping, cytogenetic assays, PCR, multi-omics, and validated bioinformatics, with study design adapted to nuclease, base-editing, prime-editing, and multiplex-editing systems. Customers primarily purchase stand-alone assays or integrated packages spanning discovery, lead optimization, preclinical development, IND-enabling studies, and clinical follow-up. The blended gross margin is approximately 55%.
Market Trends
The industry is moving from limited validation of predicted loci toward orthogonal workflows that combine computational screening, unbiased cell-based or biochemical nomination, targeted deep confirmation, and structural-variant assessment. Short-read sequencing remains the main platform for scalable quantification and confirmation, while long-read sequencing is increasingly used to resolve complex rearrangements, large deletions, and insertions. Dedicated workflows are also emerging for base editors, prime editors, multiplex editing, and different delivery systems. Customers increasingly evaluate providers on access to relevant cell models, sensitivity for low-frequency events, coverage of donor and population variation, method-validation status, data traceability, and regulatory-reporting experience, shifting demand from stand-alone sequencing toward integrated safety programs.Drivers
As gene editing pipelines advance into preclinical and clinical development, candidate-editor screening, off-target risk control, genome integrity assessment, and long-term safety monitoring are becoming mandatory budget items. More specific regulatory expectations for product design, manufacturing testing, nonclinical safety, and clinical follow-up are expanding the required evidence package. In vivo editing and allogeneic cell therapy add demand for tissue distribution, immune-response, and complex-rearrangement assessment, increasing both the breadth and technical depth of outsourced studies.Restraints
Safety studies often require therapeutically relevant cells, multiple donors, matched controls, and high sequencing depth, making sample preparation and method development difficult to standardize. Some low-frequency events approach platform noise limits, while complex genomic regions, clonal selection, and cell culture can introduce background variants. These factors raise project cost and duration and require sponsors to reserve adequate material, controls, and validation budgets early in development.Opportunities
Base editing, prime editing, multiplex editing, and individualized products create new analytical requirements for RNA off-target effects, non-double-strand-break editing outcomes, population variation, and complex structural events. Providers that integrate editing-system design, sample processing, unbiased nomination, confirmation testing, whole-genome integrity analysis, toxicology, and regulatory reporting within one project framework can reduce inter-laboratory variability and duplicate validation, capturing a larger share of program value.Challenges
The sector still lacks fully harmonized assay combinations, positivity thresholds, and standards for interpreting biological risk, and results may vary across platforms, experimental conditions, and bioinformatics pipelines. Providers must also respond to rapid editor innovation, updates to reference genomes and variant databases, data-security obligations, and cross-regional compliance requirements while avoiding the assumption that every detectable molecular event represents a confirmed clinical hazard.Value Chain Analysis
Upstream inputs include short- and long-read sequencing platforms, PCR and cytogenetic instruments, library-preparation reagents, reference materials, cell models, reference genomes, and analytical software. Midstream providers design studies, process samples, nominate and confirm sites, analyze data, manage quality, and prepare regulatory-ready reports. Downstream customers include gene and cell therapy developers, pharmaceutical and biotechnology companies, research institutions, and other industries using genome editing. The principal value is not raw sequencing output but an evidence chain connecting editing mechanism, sample background, detection limits, structural variation, and biological impact to candidate selection and regulatory communication. Major costs arise from deep sequencing, specialized reagents, scientific labor, bioinformatics, quality systems, and project management, while proprietary methods, validated workflows, and regulatory experience determine pricing power and margin.Segment Insights
By service scope, off-target nomination and confirmation remain the demand foundation and are commonly purchased together with on-target outcome and structural-variant assessment. Integrated safety packages carry higher project values and stronger growth as candidates approach regulatory submission. By technology, targeted amplicon sequencing retains a central role because of its depth, cost, and throughput; unbiased cell-based or biochemical break mapping supports site nomination; short-read whole-genome sequencing broadens variant screening; and long-read platforms are gaining use for complex rearrangements and difficult genomic regions. Preclinical and IND-enabling studies concentrate the highest-value work because they require stronger method performance, quality controls, and reporting completeness.Downstream Market Opportunities
Ex vivo edited cell therapies are the most established demand source because samples are accessible and editing sites and cellular backgrounds are comparatively well defined, enabling systematic nomination and confirmation. In vivo genome editing offers faster opportunity growth but requires more complex evaluation of tissue distribution, delivery systems, immune responses, low-frequency tissue editing, and long-term effects. Drug discovery, disease modeling, and basic research are more sensitive to price and turnaround time, while agricultural and industrial biotechnology emphasize trait stability, unintended variation, and compatibility with diverse reference genomes.Regional Insights
North America has the densest concentration of therapeutic genome editing companies, specialized analytical platforms, and regulatory-submission experience, making it the principal region for high-value outsourcing and commercialization of new assays. Europe has strong capabilities in cell therapy, genomics, and quality systems, with customers placing greater emphasis on multi-region filing compatibility and data governance. Asia Pacific is expanding through biopharmaceutical investment, growing clinical activity, and local laboratory capacity in China, Japan, South Korea, and Singapore. However, complex unbiased testing and integrated regulatory packages remain concentrated among a limited number of platforms, creating opportunities for cross-border partnerships and localized validation.Competitive Landscape Analysis
The market combines specialized technology platforms with integrated CROs. Specialist providers differentiate through proprietary nomination methods, variant-aware analysis, break-site mapping, or structural-rearrangement assays and often build strong technical retention in early editor selection and high-sensitivity genomic risk assessment. Large CROs and global testing groups compete through GLP or GxP systems, animal studies, clinical-sample networks, toxicology, and regulatory delivery across multiple development stages. Competition is shifting from isolated assay performance toward orthogonal method portfolios, relevant-cell handling, validation, integrated data interpretation, and submission-ready reporting. Partnerships, licensing, and acquisitions are increasingly used to connect editing tools, analytical assays, and broader safety-development capabilities.Report Scope
This report studies the global Gene Editing Safety Assessment Services demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Gene Editing Safety Assessment Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Editing Safety Assessment Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Gene Editing Safety Assessment Services total market, 2021-2032, (USD Million)
- Global Gene Editing Safety Assessment Services total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Gene Editing Safety Assessment Services total market, key domestic companies, and share, (USD Million)
- Global Gene Editing Safety Assessment Services revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Gene Editing Safety Assessment Services total market by Type, CAGR, 2021-2032, (USD Million)
- Global Gene Editing Safety Assessment Services total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Gene Editing Safety Assessment Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Gene Editing Safety Assessment Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Gene Editing Safety Assessment Services Market, Segmentation by Type:
- Discovery Screening
- Lead Optimization
- Preclinical Development
- IND-Enabling Studies
- Clinical Development
- Commercial and Lifecycle Support
Global Gene Editing Safety Assessment Services Market, Segmentation by Primary Technology Platform:
- In Silico Risk Prediction
- Targeted Amplicon Sequencing
- Genome-Wide Sequencing
- Cytogenetic and Functional Assays
- Unbiased Break-Site Mapping
Global Gene Editing Safety Assessment Services Market, Segmentation by Sample Source:
- Established Cell Lines
- Primary Somatic Cells
- Stem and Progenitor Cells
- Animal Tissues
- Clinical Specimens
- Other Biological Samples
Global Gene Editing Safety Assessment Services Market, Segmentation by Application:
- Biopharmaceutical and Cell & Gene Therapy Companies
- Clinical and Independent Testing Laboratories
- Academic and Government Research Institutes
- Agricultural Biotechnology Companies
- Industrial Biotechnology Companies
Companies Profiled:
- Integrated DNA Technologies
- MaxCyte
- Avance Biosciences
- Broken String Biosciences
- Synthego
- GenScript
- CD Genomics
- Creative Biogene
- Labcorp
- Charles River Laboratories
- BioAgilytix
- Precision for Medicine
- Franklin Bio
- Eurofins Scientific
- SGS
Key Questions Answered
1. How big is the global Gene Editing Safety Assessment Services market?2. What is the demand of the global Gene Editing Safety Assessment Services market?
3. What is the year over year growth of the global Gene Editing Safety Assessment Services market?
4. What is the total value of the global Gene Editing Safety Assessment Services market?
5. Who are the Major Players in the global Gene Editing Safety Assessment Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gene Editing Safety Assessment Services Introduction
1.2 World Gene Editing Safety Assessment Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Gene Editing Safety Assessment Services Total Market by Region (by Headquarter Location)
1.3.1 World Gene Editing Safety Assessment Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.3 China Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.4 Europe Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.5 Japan Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.6 South Korea Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.8 India Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Editing Safety Assessment Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.2 World Gene Editing Safety Assessment Services Consumption Value by Region
2.2.1 World Gene Editing Safety Assessment Services Consumption Value by Region (2021-2026)
2.2.2 World Gene Editing Safety Assessment Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.4 China Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.5 Europe Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.6 Japan Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.7 South Korea Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.8 ASEAN Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.9 India Gene Editing Safety Assessment Services Consumption Value (2021-2032)
3 WORLD GENE EDITING SAFETY ASSESSMENT SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Editing Safety Assessment Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Editing Safety Assessment Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Editing Safety Assessment Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Gene Editing Safety Assessment Services in 2025
3.3 Gene Editing Safety Assessment Services Company Evaluation Quadrant
3.4 Gene Editing Safety Assessment Services Market: Overall Company Footprint Analysis
3.4.1 Gene Editing Safety Assessment Services Market: Region Footprint
3.4.2 Gene Editing Safety Assessment Services Market: Company Product Type Footprint
3.4.3 Gene Editing Safety Assessment Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Editing Safety Assessment Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Editing Safety Assessment Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Gene Editing Safety Assessment Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Gene Editing Safety Assessment Services Consumption Value Comparison
4.2.1 United States VS China: Gene Editing Safety Assessment Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Gene Editing Safety Assessment Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Gene Editing Safety Assessment Services Companies and Market Share, 2021-2026
4.3.1 United States Based Gene Editing Safety Assessment Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Editing Safety Assessment Services Revenue, (2021-2026)
4.4 China Based Companies Gene Editing Safety Assessment Services Revenue and Market Share, 2021-2026
4.4.1 China Based Gene Editing Safety Assessment Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Editing Safety Assessment Services Revenue, (2021-2026)
4.5 Rest of World Based Gene Editing Safety Assessment Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Gene Editing Safety Assessment Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Gene Editing Safety Assessment Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Editing Safety Assessment Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Discovery Screening
5.2.2 Lead Optimization
5.2.3 Preclinical Development
5.2.4 IND-Enabling Studies
5.2.5 Clinical Development
5.2.6 Commercial and Lifecycle Support
5.3 Market Segment by Type
5.3.1 World Gene Editing Safety Assessment Services Market Size by Type (2021-2026)
5.3.2 World Gene Editing Safety Assessment Services Market Size by Type (2027-2032)
5.3.3 World Gene Editing Safety Assessment Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PRIMARY TECHNOLOGY PLATFORM
6.1 World Gene Editing Safety Assessment Services Market Size Overview by Primary Technology Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Primary Technology Platform
6.2.1 In Silico Risk Prediction
6.2.2 Targeted Amplicon Sequencing
6.2.3 Genome-Wide Sequencing
6.2.4 Cytogenetic and Functional Assays
6.2.5 Unbiased Break-Site Mapping
6.3 Market Segment by Primary Technology Platform
6.3.1 World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform (2021-2026)
6.3.2 World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform (2027-2032)
6.3.3 World Gene Editing Safety Assessment Services Market Size Market Share by Primary Technology Platform (2027-2032)
7 MARKET ANALYSIS BY SAMPLE SOURCE
7.1 World Gene Editing Safety Assessment Services Market Size Overview by Sample Source: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sample Source
7.2.1 Established Cell Lines
7.2.2 Primary Somatic Cells
7.2.3 Stem and Progenitor Cells
7.2.4 Animal Tissues
7.2.5 Clinical Specimens
7.2.6 Other Biological Samples
7.3 Market Segment by Sample Source
7.3.1 World Gene Editing Safety Assessment Services Market Size by Sample Source (2021-2026)
7.3.2 World Gene Editing Safety Assessment Services Market Size by Sample Source (2027-2032)
7.3.3 World Gene Editing Safety Assessment Services Market Size Market Share by Sample Source (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Gene Editing Safety Assessment Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biopharmaceutical and Cell & Gene Therapy Companies
8.2.2 Clinical and Independent Testing Laboratories
8.2.3 Academic and Government Research Institutes
8.2.4 Agricultural Biotechnology Companies
8.2.5 Industrial Biotechnology Companies
8.3 Market Segment by Application
8.3.1 World Gene Editing Safety Assessment Services Market Size by Application (2021-2026)
8.3.2 World Gene Editing Safety Assessment Services Market Size by Application (2027-2032)
8.3.3 World Gene Editing Safety Assessment Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Integrated DNA Technologies
9.1.1 Integrated DNA Technologies Details
9.1.2 Integrated DNA Technologies Major Business
9.1.3 Integrated DNA Technologies Gene Editing Safety Assessment Services Product and Services
9.1.4 Integrated DNA Technologies Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Integrated DNA Technologies Recent Developments/Updates
9.1.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
9.2 MaxCyte
9.2.1 MaxCyte Details
9.2.2 MaxCyte Major Business
9.2.3 MaxCyte Gene Editing Safety Assessment Services Product and Services
9.2.4 MaxCyte Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 MaxCyte Recent Developments/Updates
9.2.6 MaxCyte Competitive Strengths & Weaknesses
9.3 Avance Biosciences
9.3.1 Avance Biosciences Details
9.3.2 Avance Biosciences Major Business
9.3.3 Avance Biosciences Gene Editing Safety Assessment Services Product and Services
9.3.4 Avance Biosciences Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Avance Biosciences Recent Developments/Updates
9.3.6 Avance Biosciences Competitive Strengths & Weaknesses
9.4 Broken String Biosciences
9.4.1 Broken String Biosciences Details
9.4.2 Broken String Biosciences Major Business
9.4.3 Broken String Biosciences Gene Editing Safety Assessment Services Product and Services
9.4.4 Broken String Biosciences Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Broken String Biosciences Recent Developments/Updates
9.4.6 Broken String Biosciences Competitive Strengths & Weaknesses
9.5 Synthego
9.5.1 Synthego Details
9.5.2 Synthego Major Business
9.5.3 Synthego Gene Editing Safety Assessment Services Product and Services
9.5.4 Synthego Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Synthego Recent Developments/Updates
9.5.6 Synthego Competitive Strengths & Weaknesses
9.6 GenScript
9.6.1 GenScript Details
9.6.2 GenScript Major Business
9.6.3 GenScript Gene Editing Safety Assessment Services Product and Services
9.6.4 GenScript Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GenScript Recent Developments/Updates
9.6.6 GenScript Competitive Strengths & Weaknesses
9.7 CD Genomics
9.7.1 CD Genomics Details
9.7.2 CD Genomics Major Business
9.7.3 CD Genomics Gene Editing Safety Assessment Services Product and Services
9.7.4 CD Genomics Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CD Genomics Recent Developments/Updates
9.7.6 CD Genomics Competitive Strengths & Weaknesses
9.8 Creative Biogene
9.8.1 Creative Biogene Details
9.8.2 Creative Biogene Major Business
9.8.3 Creative Biogene Gene Editing Safety Assessment Services Product and Services
9.8.4 Creative Biogene Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Creative Biogene Recent Developments/Updates
9.8.6 Creative Biogene Competitive Strengths & Weaknesses
9.9 Labcorp
9.9.1 Labcorp Details
9.9.2 Labcorp Major Business
9.9.3 Labcorp Gene Editing Safety Assessment Services Product and Services
9.9.4 Labcorp Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Labcorp Recent Developments/Updates
9.9.6 Labcorp Competitive Strengths & Weaknesses
9.10 Charles River Laboratories
9.10.1 Charles River Laboratories Details
9.10.2 Charles River Laboratories Major Business
9.10.3 Charles River Laboratories Gene Editing Safety Assessment Services Product and Services
9.10.4 Charles River Laboratories Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Charles River Laboratories Recent Developments/Updates
9.10.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.11 BioAgilytix
9.11.1 BioAgilytix Details
9.11.2 BioAgilytix Major Business
9.11.3 BioAgilytix Gene Editing Safety Assessment Services Product and Services
9.11.4 BioAgilytix Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BioAgilytix Recent Developments/Updates
9.11.6 BioAgilytix Competitive Strengths & Weaknesses
9.12 Precision for Medicine
9.12.1 Precision for Medicine Details
9.12.2 Precision for Medicine Major Business
9.12.3 Precision for Medicine Gene Editing Safety Assessment Services Product and Services
9.12.4 Precision for Medicine Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Precision for Medicine Recent Developments/Updates
9.12.6 Precision for Medicine Competitive Strengths & Weaknesses
9.13 Franklin Bio
9.13.1 Franklin Bio Details
9.13.2 Franklin Bio Major Business
9.13.3 Franklin Bio Gene Editing Safety Assessment Services Product and Services
9.13.4 Franklin Bio Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Franklin Bio Recent Developments/Updates
9.13.6 Franklin Bio Competitive Strengths & Weaknesses
9.14 Eurofins Scientific
9.14.1 Eurofins Scientific Details
9.14.2 Eurofins Scientific Major Business
9.14.3 Eurofins Scientific Gene Editing Safety Assessment Services Product and Services
9.14.4 Eurofins Scientific Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Eurofins Scientific Recent Developments/Updates
9.14.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.15 SGS
9.15.1 SGS Details
9.15.2 SGS Major Business
9.15.3 SGS Gene Editing Safety Assessment Services Product and Services
9.15.4 SGS Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 SGS Recent Developments/Updates
9.15.6 SGS Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Gene Editing Safety Assessment Services Industry Chain
10.2 Gene Editing Safety Assessment Services Upstream Analysis
10.3 Gene Editing Safety Assessment Services Midstream Analysis
10.4 Gene Editing Safety Assessment Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Gene Editing Safety Assessment Services Introduction
1.2 World Gene Editing Safety Assessment Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Gene Editing Safety Assessment Services Total Market by Region (by Headquarter Location)
1.3.1 World Gene Editing Safety Assessment Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.3 China Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.4 Europe Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.5 Japan Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.6 South Korea Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.3.8 India Based Company Gene Editing Safety Assessment Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Editing Safety Assessment Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.2 World Gene Editing Safety Assessment Services Consumption Value by Region
2.2.1 World Gene Editing Safety Assessment Services Consumption Value by Region (2021-2026)
2.2.2 World Gene Editing Safety Assessment Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.4 China Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.5 Europe Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.6 Japan Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.7 South Korea Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.8 ASEAN Gene Editing Safety Assessment Services Consumption Value (2021-2032)
2.9 India Gene Editing Safety Assessment Services Consumption Value (2021-2032)
3 WORLD GENE EDITING SAFETY ASSESSMENT SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Editing Safety Assessment Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Editing Safety Assessment Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Editing Safety Assessment Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Gene Editing Safety Assessment Services in 2025
3.3 Gene Editing Safety Assessment Services Company Evaluation Quadrant
3.4 Gene Editing Safety Assessment Services Market: Overall Company Footprint Analysis
3.4.1 Gene Editing Safety Assessment Services Market: Region Footprint
3.4.2 Gene Editing Safety Assessment Services Market: Company Product Type Footprint
3.4.3 Gene Editing Safety Assessment Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Editing Safety Assessment Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Editing Safety Assessment Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Gene Editing Safety Assessment Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Gene Editing Safety Assessment Services Consumption Value Comparison
4.2.1 United States VS China: Gene Editing Safety Assessment Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Gene Editing Safety Assessment Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Gene Editing Safety Assessment Services Companies and Market Share, 2021-2026
4.3.1 United States Based Gene Editing Safety Assessment Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Editing Safety Assessment Services Revenue, (2021-2026)
4.4 China Based Companies Gene Editing Safety Assessment Services Revenue and Market Share, 2021-2026
4.4.1 China Based Gene Editing Safety Assessment Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Editing Safety Assessment Services Revenue, (2021-2026)
4.5 Rest of World Based Gene Editing Safety Assessment Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Gene Editing Safety Assessment Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Gene Editing Safety Assessment Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Editing Safety Assessment Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Discovery Screening
5.2.2 Lead Optimization
5.2.3 Preclinical Development
5.2.4 IND-Enabling Studies
5.2.5 Clinical Development
5.2.6 Commercial and Lifecycle Support
5.3 Market Segment by Type
5.3.1 World Gene Editing Safety Assessment Services Market Size by Type (2021-2026)
5.3.2 World Gene Editing Safety Assessment Services Market Size by Type (2027-2032)
5.3.3 World Gene Editing Safety Assessment Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PRIMARY TECHNOLOGY PLATFORM
6.1 World Gene Editing Safety Assessment Services Market Size Overview by Primary Technology Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Primary Technology Platform
6.2.1 In Silico Risk Prediction
6.2.2 Targeted Amplicon Sequencing
6.2.3 Genome-Wide Sequencing
6.2.4 Cytogenetic and Functional Assays
6.2.5 Unbiased Break-Site Mapping
6.3 Market Segment by Primary Technology Platform
6.3.1 World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform (2021-2026)
6.3.2 World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform (2027-2032)
6.3.3 World Gene Editing Safety Assessment Services Market Size Market Share by Primary Technology Platform (2027-2032)
7 MARKET ANALYSIS BY SAMPLE SOURCE
7.1 World Gene Editing Safety Assessment Services Market Size Overview by Sample Source: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sample Source
7.2.1 Established Cell Lines
7.2.2 Primary Somatic Cells
7.2.3 Stem and Progenitor Cells
7.2.4 Animal Tissues
7.2.5 Clinical Specimens
7.2.6 Other Biological Samples
7.3 Market Segment by Sample Source
7.3.1 World Gene Editing Safety Assessment Services Market Size by Sample Source (2021-2026)
7.3.2 World Gene Editing Safety Assessment Services Market Size by Sample Source (2027-2032)
7.3.3 World Gene Editing Safety Assessment Services Market Size Market Share by Sample Source (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Gene Editing Safety Assessment Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biopharmaceutical and Cell & Gene Therapy Companies
8.2.2 Clinical and Independent Testing Laboratories
8.2.3 Academic and Government Research Institutes
8.2.4 Agricultural Biotechnology Companies
8.2.5 Industrial Biotechnology Companies
8.3 Market Segment by Application
8.3.1 World Gene Editing Safety Assessment Services Market Size by Application (2021-2026)
8.3.2 World Gene Editing Safety Assessment Services Market Size by Application (2027-2032)
8.3.3 World Gene Editing Safety Assessment Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Integrated DNA Technologies
9.1.1 Integrated DNA Technologies Details
9.1.2 Integrated DNA Technologies Major Business
9.1.3 Integrated DNA Technologies Gene Editing Safety Assessment Services Product and Services
9.1.4 Integrated DNA Technologies Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Integrated DNA Technologies Recent Developments/Updates
9.1.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
9.2 MaxCyte
9.2.1 MaxCyte Details
9.2.2 MaxCyte Major Business
9.2.3 MaxCyte Gene Editing Safety Assessment Services Product and Services
9.2.4 MaxCyte Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 MaxCyte Recent Developments/Updates
9.2.6 MaxCyte Competitive Strengths & Weaknesses
9.3 Avance Biosciences
9.3.1 Avance Biosciences Details
9.3.2 Avance Biosciences Major Business
9.3.3 Avance Biosciences Gene Editing Safety Assessment Services Product and Services
9.3.4 Avance Biosciences Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Avance Biosciences Recent Developments/Updates
9.3.6 Avance Biosciences Competitive Strengths & Weaknesses
9.4 Broken String Biosciences
9.4.1 Broken String Biosciences Details
9.4.2 Broken String Biosciences Major Business
9.4.3 Broken String Biosciences Gene Editing Safety Assessment Services Product and Services
9.4.4 Broken String Biosciences Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Broken String Biosciences Recent Developments/Updates
9.4.6 Broken String Biosciences Competitive Strengths & Weaknesses
9.5 Synthego
9.5.1 Synthego Details
9.5.2 Synthego Major Business
9.5.3 Synthego Gene Editing Safety Assessment Services Product and Services
9.5.4 Synthego Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Synthego Recent Developments/Updates
9.5.6 Synthego Competitive Strengths & Weaknesses
9.6 GenScript
9.6.1 GenScript Details
9.6.2 GenScript Major Business
9.6.3 GenScript Gene Editing Safety Assessment Services Product and Services
9.6.4 GenScript Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GenScript Recent Developments/Updates
9.6.6 GenScript Competitive Strengths & Weaknesses
9.7 CD Genomics
9.7.1 CD Genomics Details
9.7.2 CD Genomics Major Business
9.7.3 CD Genomics Gene Editing Safety Assessment Services Product and Services
9.7.4 CD Genomics Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CD Genomics Recent Developments/Updates
9.7.6 CD Genomics Competitive Strengths & Weaknesses
9.8 Creative Biogene
9.8.1 Creative Biogene Details
9.8.2 Creative Biogene Major Business
9.8.3 Creative Biogene Gene Editing Safety Assessment Services Product and Services
9.8.4 Creative Biogene Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Creative Biogene Recent Developments/Updates
9.8.6 Creative Biogene Competitive Strengths & Weaknesses
9.9 Labcorp
9.9.1 Labcorp Details
9.9.2 Labcorp Major Business
9.9.3 Labcorp Gene Editing Safety Assessment Services Product and Services
9.9.4 Labcorp Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Labcorp Recent Developments/Updates
9.9.6 Labcorp Competitive Strengths & Weaknesses
9.10 Charles River Laboratories
9.10.1 Charles River Laboratories Details
9.10.2 Charles River Laboratories Major Business
9.10.3 Charles River Laboratories Gene Editing Safety Assessment Services Product and Services
9.10.4 Charles River Laboratories Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Charles River Laboratories Recent Developments/Updates
9.10.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.11 BioAgilytix
9.11.1 BioAgilytix Details
9.11.2 BioAgilytix Major Business
9.11.3 BioAgilytix Gene Editing Safety Assessment Services Product and Services
9.11.4 BioAgilytix Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BioAgilytix Recent Developments/Updates
9.11.6 BioAgilytix Competitive Strengths & Weaknesses
9.12 Precision for Medicine
9.12.1 Precision for Medicine Details
9.12.2 Precision for Medicine Major Business
9.12.3 Precision for Medicine Gene Editing Safety Assessment Services Product and Services
9.12.4 Precision for Medicine Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Precision for Medicine Recent Developments/Updates
9.12.6 Precision for Medicine Competitive Strengths & Weaknesses
9.13 Franklin Bio
9.13.1 Franklin Bio Details
9.13.2 Franklin Bio Major Business
9.13.3 Franklin Bio Gene Editing Safety Assessment Services Product and Services
9.13.4 Franklin Bio Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Franklin Bio Recent Developments/Updates
9.13.6 Franklin Bio Competitive Strengths & Weaknesses
9.14 Eurofins Scientific
9.14.1 Eurofins Scientific Details
9.14.2 Eurofins Scientific Major Business
9.14.3 Eurofins Scientific Gene Editing Safety Assessment Services Product and Services
9.14.4 Eurofins Scientific Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Eurofins Scientific Recent Developments/Updates
9.14.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.15 SGS
9.15.1 SGS Details
9.15.2 SGS Major Business
9.15.3 SGS Gene Editing Safety Assessment Services Product and Services
9.15.4 SGS Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 SGS Recent Developments/Updates
9.15.6 SGS Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Gene Editing Safety Assessment Services Industry Chain
10.2 Gene Editing Safety Assessment Services Upstream Analysis
10.3 Gene Editing Safety Assessment Services Midstream Analysis
10.4 Gene Editing Safety Assessment Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Gene Editing Safety Assessment Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Gene Editing Safety Assessment Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Gene Editing Safety Assessment Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Gene Editing Safety Assessment Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Gene Editing Safety Assessment Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Editing Safety Assessment Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Gene Editing Safety Assessment Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Gene Editing Safety Assessment Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Gene Editing Safety Assessment Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Gene Editing Safety Assessment Services Players in 2025
Table 12. World Gene Editing Safety Assessment Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Gene Editing Safety Assessment Services Company Evaluation Quadrant
Table 14. Head Office of Key Gene Editing Safety Assessment Services Players
Table 15. Gene Editing Safety Assessment Services Market: Company Product Type Footprint
Table 16. Gene Editing Safety Assessment Services Market: Company Product Application Footprint
Table 17. Gene Editing Safety Assessment Services Mergers & Acquisitions Activity
Table 18. United States VS China Gene Editing Safety Assessment Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Gene Editing Safety Assessment Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Gene Editing Safety Assessment Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Editing Safety Assessment Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Gene Editing Safety Assessment Services Revenue Market Share (2021-2026)
Table 23. China Based Gene Editing Safety Assessment Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Editing Safety Assessment Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Gene Editing Safety Assessment Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Gene Editing Safety Assessment Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Gene Editing Safety Assessment Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Gene Editing Safety Assessment Services Revenue Market Share (2021-2026)
Table 29. World Gene Editing Safety Assessment Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Gene Editing Safety Assessment Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Gene Editing Safety Assessment Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 33. World Gene Editing Safety Assessment Services Market Size Value by Primary Technology Platform (2021-2026) & (USD Million)
Table 34. World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform (2027-2032) & (USD Million)
Table 35. World Gene Editing Safety Assessment Services Market Size by Sample Source, (USD Million), 2021 & 2025 & 2032
Table 36. World Gene Editing Safety Assessment Services Market Size Value by Sample Source (2021-2026) & (USD Million)
Table 37. World Gene Editing Safety Assessment Services Market Size by Sample Source (2027-2032) & (USD Million)
Table 38. World Gene Editing Safety Assessment Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Gene Editing Safety Assessment Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Gene Editing Safety Assessment Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Integrated DNA Technologies Basic Information, Manufacturing Base and Competitors
Table 42. Integrated DNA Technologies Major Business
Table 43. Integrated DNA Technologies Gene Editing Safety Assessment Services Product and Services
Table 44. Integrated DNA Technologies Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Integrated DNA Technologies Recent Developments/Updates
Table 46. Integrated DNA Technologies Competitive Strengths & Weaknesses
Table 47. MaxCyte Basic Information, Manufacturing Base and Competitors
Table 48. MaxCyte Major Business
Table 49. MaxCyte Gene Editing Safety Assessment Services Product and Services
Table 50. MaxCyte Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. MaxCyte Recent Developments/Updates
Table 52. MaxCyte Competitive Strengths & Weaknesses
Table 53. Avance Biosciences Basic Information, Manufacturing Base and Competitors
Table 54. Avance Biosciences Major Business
Table 55. Avance Biosciences Gene Editing Safety Assessment Services Product and Services
Table 56. Avance Biosciences Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Avance Biosciences Recent Developments/Updates
Table 58. Avance Biosciences Competitive Strengths & Weaknesses
Table 59. Broken String Biosciences Basic Information, Manufacturing Base and Competitors
Table 60. Broken String Biosciences Major Business
Table 61. Broken String Biosciences Gene Editing Safety Assessment Services Product and Services
Table 62. Broken String Biosciences Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Broken String Biosciences Recent Developments/Updates
Table 64. Broken String Biosciences Competitive Strengths & Weaknesses
Table 65. Synthego Basic Information, Manufacturing Base and Competitors
Table 66. Synthego Major Business
Table 67. Synthego Gene Editing Safety Assessment Services Product and Services
Table 68. Synthego Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Synthego Recent Developments/Updates
Table 70. Synthego Competitive Strengths & Weaknesses
Table 71. GenScript Basic Information, Manufacturing Base and Competitors
Table 72. GenScript Major Business
Table 73. GenScript Gene Editing Safety Assessment Services Product and Services
Table 74. GenScript Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GenScript Recent Developments/Updates
Table 76. GenScript Competitive Strengths & Weaknesses
Table 77. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 78. CD Genomics Major Business
Table 79. CD Genomics Gene Editing Safety Assessment Services Product and Services
Table 80. CD Genomics Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CD Genomics Recent Developments/Updates
Table 82. CD Genomics Competitive Strengths & Weaknesses
Table 83. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 84. Creative Biogene Major Business
Table 85. Creative Biogene Gene Editing Safety Assessment Services Product and Services
Table 86. Creative Biogene Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Creative Biogene Recent Developments/Updates
Table 88. Creative Biogene Competitive Strengths & Weaknesses
Table 89. Labcorp Basic Information, Manufacturing Base and Competitors
Table 90. Labcorp Major Business
Table 91. Labcorp Gene Editing Safety Assessment Services Product and Services
Table 92. Labcorp Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Labcorp Recent Developments/Updates
Table 94. Labcorp Competitive Strengths & Weaknesses
Table 95. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 96. Charles River Laboratories Major Business
Table 97. Charles River Laboratories Gene Editing Safety Assessment Services Product and Services
Table 98. Charles River Laboratories Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Charles River Laboratories Recent Developments/Updates
Table 100. Charles River Laboratories Competitive Strengths & Weaknesses
Table 101. BioAgilytix Basic Information, Manufacturing Base and Competitors
Table 102. BioAgilytix Major Business
Table 103. BioAgilytix Gene Editing Safety Assessment Services Product and Services
Table 104. BioAgilytix Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BioAgilytix Recent Developments/Updates
Table 106. BioAgilytix Competitive Strengths & Weaknesses
Table 107. Precision for Medicine Basic Information, Manufacturing Base and Competitors
Table 108. Precision for Medicine Major Business
Table 109. Precision for Medicine Gene Editing Safety Assessment Services Product and Services
Table 110. Precision for Medicine Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Precision for Medicine Recent Developments/Updates
Table 112. Precision for Medicine Competitive Strengths & Weaknesses
Table 113. Franklin Bio Basic Information, Manufacturing Base and Competitors
Table 114. Franklin Bio Major Business
Table 115. Franklin Bio Gene Editing Safety Assessment Services Product and Services
Table 116. Franklin Bio Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Franklin Bio Recent Developments/Updates
Table 118. Franklin Bio Competitive Strengths & Weaknesses
Table 119. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 120. Eurofins Scientific Major Business
Table 121. Eurofins Scientific Gene Editing Safety Assessment Services Product and Services
Table 122. Eurofins Scientific Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Eurofins Scientific Recent Developments/Updates
Table 124. Eurofins Scientific Competitive Strengths & Weaknesses
Table 125. SGS Basic Information, Manufacturing Base and Competitors
Table 126. SGS Major Business
Table 127. SGS Gene Editing Safety Assessment Services Product and Services
Table 128. SGS Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. SGS Recent Developments/Updates
Table 130. SGS Competitive Strengths & Weaknesses
Table 131. Global Key Players of Gene Editing Safety Assessment Services Upstream (Raw Materials)
Table 132. Global Gene Editing Safety Assessment Services Typical Customers
Table 1. World Gene Editing Safety Assessment Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Gene Editing Safety Assessment Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Gene Editing Safety Assessment Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Gene Editing Safety Assessment Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Gene Editing Safety Assessment Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Editing Safety Assessment Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Gene Editing Safety Assessment Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Gene Editing Safety Assessment Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Gene Editing Safety Assessment Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Gene Editing Safety Assessment Services Players in 2025
Table 12. World Gene Editing Safety Assessment Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Gene Editing Safety Assessment Services Company Evaluation Quadrant
Table 14. Head Office of Key Gene Editing Safety Assessment Services Players
Table 15. Gene Editing Safety Assessment Services Market: Company Product Type Footprint
Table 16. Gene Editing Safety Assessment Services Market: Company Product Application Footprint
Table 17. Gene Editing Safety Assessment Services Mergers & Acquisitions Activity
Table 18. United States VS China Gene Editing Safety Assessment Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Gene Editing Safety Assessment Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Gene Editing Safety Assessment Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Editing Safety Assessment Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Gene Editing Safety Assessment Services Revenue Market Share (2021-2026)
Table 23. China Based Gene Editing Safety Assessment Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Editing Safety Assessment Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Gene Editing Safety Assessment Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Gene Editing Safety Assessment Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Gene Editing Safety Assessment Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Gene Editing Safety Assessment Services Revenue Market Share (2021-2026)
Table 29. World Gene Editing Safety Assessment Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Gene Editing Safety Assessment Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Gene Editing Safety Assessment Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 33. World Gene Editing Safety Assessment Services Market Size Value by Primary Technology Platform (2021-2026) & (USD Million)
Table 34. World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform (2027-2032) & (USD Million)
Table 35. World Gene Editing Safety Assessment Services Market Size by Sample Source, (USD Million), 2021 & 2025 & 2032
Table 36. World Gene Editing Safety Assessment Services Market Size Value by Sample Source (2021-2026) & (USD Million)
Table 37. World Gene Editing Safety Assessment Services Market Size by Sample Source (2027-2032) & (USD Million)
Table 38. World Gene Editing Safety Assessment Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Gene Editing Safety Assessment Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Gene Editing Safety Assessment Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Integrated DNA Technologies Basic Information, Manufacturing Base and Competitors
Table 42. Integrated DNA Technologies Major Business
Table 43. Integrated DNA Technologies Gene Editing Safety Assessment Services Product and Services
Table 44. Integrated DNA Technologies Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Integrated DNA Technologies Recent Developments/Updates
Table 46. Integrated DNA Technologies Competitive Strengths & Weaknesses
Table 47. MaxCyte Basic Information, Manufacturing Base and Competitors
Table 48. MaxCyte Major Business
Table 49. MaxCyte Gene Editing Safety Assessment Services Product and Services
Table 50. MaxCyte Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. MaxCyte Recent Developments/Updates
Table 52. MaxCyte Competitive Strengths & Weaknesses
Table 53. Avance Biosciences Basic Information, Manufacturing Base and Competitors
Table 54. Avance Biosciences Major Business
Table 55. Avance Biosciences Gene Editing Safety Assessment Services Product and Services
Table 56. Avance Biosciences Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Avance Biosciences Recent Developments/Updates
Table 58. Avance Biosciences Competitive Strengths & Weaknesses
Table 59. Broken String Biosciences Basic Information, Manufacturing Base and Competitors
Table 60. Broken String Biosciences Major Business
Table 61. Broken String Biosciences Gene Editing Safety Assessment Services Product and Services
Table 62. Broken String Biosciences Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Broken String Biosciences Recent Developments/Updates
Table 64. Broken String Biosciences Competitive Strengths & Weaknesses
Table 65. Synthego Basic Information, Manufacturing Base and Competitors
Table 66. Synthego Major Business
Table 67. Synthego Gene Editing Safety Assessment Services Product and Services
Table 68. Synthego Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Synthego Recent Developments/Updates
Table 70. Synthego Competitive Strengths & Weaknesses
Table 71. GenScript Basic Information, Manufacturing Base and Competitors
Table 72. GenScript Major Business
Table 73. GenScript Gene Editing Safety Assessment Services Product and Services
Table 74. GenScript Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GenScript Recent Developments/Updates
Table 76. GenScript Competitive Strengths & Weaknesses
Table 77. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 78. CD Genomics Major Business
Table 79. CD Genomics Gene Editing Safety Assessment Services Product and Services
Table 80. CD Genomics Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CD Genomics Recent Developments/Updates
Table 82. CD Genomics Competitive Strengths & Weaknesses
Table 83. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 84. Creative Biogene Major Business
Table 85. Creative Biogene Gene Editing Safety Assessment Services Product and Services
Table 86. Creative Biogene Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Creative Biogene Recent Developments/Updates
Table 88. Creative Biogene Competitive Strengths & Weaknesses
Table 89. Labcorp Basic Information, Manufacturing Base and Competitors
Table 90. Labcorp Major Business
Table 91. Labcorp Gene Editing Safety Assessment Services Product and Services
Table 92. Labcorp Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Labcorp Recent Developments/Updates
Table 94. Labcorp Competitive Strengths & Weaknesses
Table 95. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 96. Charles River Laboratories Major Business
Table 97. Charles River Laboratories Gene Editing Safety Assessment Services Product and Services
Table 98. Charles River Laboratories Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Charles River Laboratories Recent Developments/Updates
Table 100. Charles River Laboratories Competitive Strengths & Weaknesses
Table 101. BioAgilytix Basic Information, Manufacturing Base and Competitors
Table 102. BioAgilytix Major Business
Table 103. BioAgilytix Gene Editing Safety Assessment Services Product and Services
Table 104. BioAgilytix Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BioAgilytix Recent Developments/Updates
Table 106. BioAgilytix Competitive Strengths & Weaknesses
Table 107. Precision for Medicine Basic Information, Manufacturing Base and Competitors
Table 108. Precision for Medicine Major Business
Table 109. Precision for Medicine Gene Editing Safety Assessment Services Product and Services
Table 110. Precision for Medicine Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Precision for Medicine Recent Developments/Updates
Table 112. Precision for Medicine Competitive Strengths & Weaknesses
Table 113. Franklin Bio Basic Information, Manufacturing Base and Competitors
Table 114. Franklin Bio Major Business
Table 115. Franklin Bio Gene Editing Safety Assessment Services Product and Services
Table 116. Franklin Bio Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Franklin Bio Recent Developments/Updates
Table 118. Franklin Bio Competitive Strengths & Weaknesses
Table 119. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 120. Eurofins Scientific Major Business
Table 121. Eurofins Scientific Gene Editing Safety Assessment Services Product and Services
Table 122. Eurofins Scientific Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Eurofins Scientific Recent Developments/Updates
Table 124. Eurofins Scientific Competitive Strengths & Weaknesses
Table 125. SGS Basic Information, Manufacturing Base and Competitors
Table 126. SGS Major Business
Table 127. SGS Gene Editing Safety Assessment Services Product and Services
Table 128. SGS Gene Editing Safety Assessment Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. SGS Recent Developments/Updates
Table 130. SGS Competitive Strengths & Weaknesses
Table 131. Global Key Players of Gene Editing Safety Assessment Services Upstream (Raw Materials)
Table 132. Global Gene Editing Safety Assessment Services Typical Customers
LIST OF FIGURES
Figure 1. Gene Editing Safety Assessment Services Picture
Figure 2. World Gene Editing Safety Assessment Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Gene Editing Safety Assessment Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Gene Editing Safety Assessment Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Gene Editing Safety Assessment Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 13. Gene Editing Safety Assessment Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Gene Editing Safety Assessment Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Gene Editing Safety Assessment Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Editing Safety Assessment Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Editing Safety Assessment Services Markets in 2025
Figure 27. United States VS China: Gene Editing Safety Assessment Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Gene Editing Safety Assessment Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Gene Editing Safety Assessment Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Gene Editing Safety Assessment Services Market Size Market Share by Type in 2025
Figure 31. Discovery Screening
Figure 32. Lead Optimization
Figure 33. Preclinical Development
Figure 34. IND-Enabling Studies
Figure 35. Clinical Development
Figure 36. Commercial and Lifecycle Support
Figure 37. World Gene Editing Safety Assessment Services Market Size Market Share by Type (2021-2032)
Figure 38. World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 39. World Gene Editing Safety Assessment Services Market Size Market Share by Primary Technology Platform in 2025
Figure 40. In Silico Risk Prediction
Figure 41. Targeted Amplicon Sequencing
Figure 42. Genome-Wide Sequencing
Figure 43. Cytogenetic and Functional Assays
Figure 44. Unbiased Break-Site Mapping
Figure 45. World Gene Editing Safety Assessment Services Market Size Market Share by Primary Technology Platform (2021-2032)
Figure 46. World Gene Editing Safety Assessment Services Market Size by Sample Source, (USD Million), 2021 & 2025 & 2032
Figure 47. World Gene Editing Safety Assessment Services Market Size Market Share by Sample Source in 2025
Figure 48. Established Cell Lines
Figure 49. Primary Somatic Cells
Figure 50. Stem and Progenitor Cells
Figure 51. Animal Tissues
Figure 52. Clinical Specimens
Figure 53. Other Biological Samples
Figure 54. World Gene Editing Safety Assessment Services Market Size Market Share by Sample Source (2021-2032)
Figure 55. World Gene Editing Safety Assessment Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Gene Editing Safety Assessment Services Market Size Market Share by Application in 2025
Figure 57. Biopharmaceutical and Cell & Gene Therapy Companies
Figure 58. Clinical and Independent Testing Laboratories
Figure 59. Academic and Government Research Institutes
Figure 60. Agricultural Biotechnology Companies
Figure 61. Industrial Biotechnology Companies
Figure 62. World Gene Editing Safety Assessment Services Market Size Market Share by Application (2021-2032)
Figure 63. Gene Editing Safety Assessment Services Industrial Chain
Figure 64. Methodology
Figure 65. Research Process and Data Source
Figure 1. Gene Editing Safety Assessment Services Picture
Figure 2. World Gene Editing Safety Assessment Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Gene Editing Safety Assessment Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Gene Editing Safety Assessment Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Gene Editing Safety Assessment Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Gene Editing Safety Assessment Services Revenue (2021-2032) & (USD Million)
Figure 13. Gene Editing Safety Assessment Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Gene Editing Safety Assessment Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Gene Editing Safety Assessment Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Gene Editing Safety Assessment Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Editing Safety Assessment Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Editing Safety Assessment Services Markets in 2025
Figure 27. United States VS China: Gene Editing Safety Assessment Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Gene Editing Safety Assessment Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Gene Editing Safety Assessment Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Gene Editing Safety Assessment Services Market Size Market Share by Type in 2025
Figure 31. Discovery Screening
Figure 32. Lead Optimization
Figure 33. Preclinical Development
Figure 34. IND-Enabling Studies
Figure 35. Clinical Development
Figure 36. Commercial and Lifecycle Support
Figure 37. World Gene Editing Safety Assessment Services Market Size Market Share by Type (2021-2032)
Figure 38. World Gene Editing Safety Assessment Services Market Size by Primary Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 39. World Gene Editing Safety Assessment Services Market Size Market Share by Primary Technology Platform in 2025
Figure 40. In Silico Risk Prediction
Figure 41. Targeted Amplicon Sequencing
Figure 42. Genome-Wide Sequencing
Figure 43. Cytogenetic and Functional Assays
Figure 44. Unbiased Break-Site Mapping
Figure 45. World Gene Editing Safety Assessment Services Market Size Market Share by Primary Technology Platform (2021-2032)
Figure 46. World Gene Editing Safety Assessment Services Market Size by Sample Source, (USD Million), 2021 & 2025 & 2032
Figure 47. World Gene Editing Safety Assessment Services Market Size Market Share by Sample Source in 2025
Figure 48. Established Cell Lines
Figure 49. Primary Somatic Cells
Figure 50. Stem and Progenitor Cells
Figure 51. Animal Tissues
Figure 52. Clinical Specimens
Figure 53. Other Biological Samples
Figure 54. World Gene Editing Safety Assessment Services Market Size Market Share by Sample Source (2021-2032)
Figure 55. World Gene Editing Safety Assessment Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Gene Editing Safety Assessment Services Market Size Market Share by Application in 2025
Figure 57. Biopharmaceutical and Cell & Gene Therapy Companies
Figure 58. Clinical and Independent Testing Laboratories
Figure 59. Academic and Government Research Institutes
Figure 60. Agricultural Biotechnology Companies
Figure 61. Industrial Biotechnology Companies
Figure 62. World Gene Editing Safety Assessment Services Market Size Market Share by Application (2021-2032)
Figure 63. Gene Editing Safety Assessment Services Industrial Chain
Figure 64. Methodology
Figure 65. Research Process and Data Source
